Elafibranor

Elafibranor brand name - Iqirvo is a novel oral medication approved for the treatment of primary biliary cholangitis (PBC), a chronic autoimmune liver disease. Reference standards of Elafibranor API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Elafibranor
    [catalogue_number] => PA 05 2360000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 384.49
    [form] => C22H24O4S
    [cas] => 923978-27-2
    [pslug] => 923978-27-2-elafibranor-pa052360000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 05 2360000

Elafibranor


  • Catalogue No.:PA 05 2360000

  • CAS :

    923978-27-2

  • Molecular Formula : C22H24O4S

  • Molecular Weight : 384.49